Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer

অনুরূপ উপাদানগুলি

• Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
  অনুযায়ী: Arshad, M, অন্যান্য
  প্রকাশিত: (2024)
• Preclinical characteristics of the irreversible pan-HER kinase inhibitor neratinib compared with lapatinib : implications for the treatment of HER2-positive and HER2-mutated breast cancer
  অনুযায়ী: Collins, Denis M., অন্যান্য
  প্রকাশিত: (2020)
• The role of HER4 in relation to trastuzumab resistance and prognosis in HER2 positive breast cancer
  অনুযায়ী: Mohd Nafi, SN
  প্রকাশিত: (2014)
• Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
  অনুযায়ী: McLarty, K, অন্যান্য
  প্রকাশিত: (2009)
• Upregulation of ADAM proteases and HER ligands through a feedback loop mediates acquired resistance to trastuzumab in HER2-amplified breast cancer.
  অনুযায়ী: Gijsen, M, অন্যান্য
  প্রকাশিত: (2010)